Activation-independent, antibody-mediated removal of GPVI from circulating human platelets: development of a novel NOD/SCID mouse model to evaluate the in vivo effectiveness of anti-human platelet agents

Brian Boylan, Michael Claude Berndt, Mark L Kahn, Peter J Newman

Research output: Contribution to journalArticleResearchpeer-review

58 Citations (Scopus)
Original languageEnglish
Pages (from-to)908 - 914
Number of pages7
JournalBlood
Volume108
Issue number3
DOIs
Publication statusPublished - 2006

Cite this